Bergsland E - Search Results

1

Efficacy and toxicity of anti-vascular endothelial growth receptor tyrosine kinase inhibitors in patients with neuroendocrine tumours - A systematic review and meta-analysis.

Das S, Phillips S, Lee CL, Agarwal R, Bergsland E, Strosberg J, Chan JA, LaFerriere H, Ramirez RA, Berlin J, Dasari A. Das S, et al. Among authors: bergsland e. Eur J Cancer. 2023 Mar;182:43-52. doi: 10.1016/j.ejca.2022.12.031. Epub 2023 Jan 11. Eur J Cancer. 2023. PMID: 36738541 Free PMC article.

2

Temsirolimus combined with sorafenib in hepatocellular carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlates.

Kelley RK, Nimeiri HS, Munster PN, Vergo MT, Huang Y, Li CM, Hwang J, Mulcahy MF, Yeh BM, Kuhn P, Luttgen MS, Grabowsky JA, Stucky-Marshall L, Korn WM, Ko AH, Bergsland EK, Benson AB 3rd, Venook AP. Kelley RK, et al. Among authors: bergsland ek. Ann Oncol. 2013 Jul;24(7):1900-1907. doi: 10.1093/annonc/mdt109. Epub 2013 Mar 21. Ann Oncol. 2013. PMID: 23519998 Free PMC article. Clinical Trial.

3

When does the presence of the target predict response to the targeted agent?

Bergsland EK. Bergsland EK. J Clin Oncol. 2006 Jan 10;24(2):213-6. doi: 10.1200/JCO.2005.03.6913. Epub 2005 Dec 19. J Clin Oncol. 2006. PMID: 16365177 No abstract available.

4

Glycemic control in patients with insulinoma treated with everolimus.

Kulke MH, Bergsland EK, Yao JC. Kulke MH, et al. N Engl J Med. 2009 Jan 8;360(2):195-7. doi: 10.1056/NEJMc0806740. N Engl J Med. 2009. PMID: 19129539 No abstract available.

5

Angiogenesis in colorectal cancer: therapeutic implications and future directions.

Allen J, Bergsland EK. Allen J, et al. Hematol Oncol Clin North Am. 2004 Oct;18(5):1087-119, ix. doi: 10.1016/j.hoc.2004.05.002. Hematol Oncol Clin North Am. 2004. PMID: 15474337 Review.

6

Targeting growth factors and angiogenesis; using small molecules in malignancy.

Wanebo HJ, Argiris A, Bergsland E, Agarwala S, Rugo H. Wanebo HJ, et al. Among authors: bergsland e. Cancer Metastasis Rev. 2006 Jun;25(2):279-92. doi: 10.1007/s10555-006-8508-2. Cancer Metastasis Rev. 2006. PMID: 16770540 Review.

7

Couples therapy at end of life.

Mohr DC, Moran PJ, Kohn C, Hart S, Armstrong K, Dias R, Bergsland E, Folkman S. Mohr DC, et al. Among authors: bergsland e. Psychooncology. 2003 Sep;12(6):620-7. doi: 10.1002/pon.746. Psychooncology. 2003. PMID: 12923802 Clinical Trial.

8

Introduction: recent advances in the genetics, diagnosis, and treatment of neuroendocrine tumors.

Bergsland EK. Bergsland EK. Semin Oncol. 2013 Feb;40(1):1-3. doi: 10.1053/j.seminoncol.2012.12.001. Semin Oncol. 2013. PMID: 23391108 No abstract available.

9

Maximizing the potential of bevacizumab in cancer treatment.

Bergsland E, Dickler MN. Bergsland E, et al. Oncologist. 2004;9 Suppl 1:36-42. doi: 10.1634/theoncologist.9-suppl_1-36. Oncologist. 2004. PMID: 15178814 Free article. Review.

10

Optimal timing of surgery after chemoradiation for advanced rectal cancer: preliminary results of a multicenter, nonrandomized phase II prospective trial.

Garcia-Aguilar J, Smith DD, Avila K, Bergsland EK, Chu P, Krieg RM; Timing of Rectal Cancer Response to Chemoradiation Consortium. Garcia-Aguilar J, et al. Ann Surg. 2011 Jul;254(1):97-102. doi: 10.1097/SLA.0b013e3182196e1f. Ann Surg. 2011. PMID: 21494121 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

157 results

Search Page

Filters